Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicentre, Randomised, Double-blind Study Assessing the Efficacy and Safety of Penthrox Combined With a Standard Analgesia (SoC) in Comparison to a Placebo Combined With a Standard Analgesia (SoC) in Adult Patients Admitted to the Emergency Department With Moderate to Severe Pain Associated With Trauma

Next Previous
Trial Profile

Multicentre, Randomised, Double-blind Study Assessing the Efficacy and Safety of Penthrox Combined With a Standard Analgesia (SoC) in Comparison to a Placebo Combined With a Standard Analgesia (SoC) in Adult Patients Admitted to the Emergency Department With Moderate to Severe Pain Associated With Trauma

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Methoxyflurane (Primary) ; Analgesics
  • Indications Pain
  • Focus Therapeutic Use
  • Acronyms Pen ASAP
  • Sponsors Mundipharma International

Most Recent Events

  • 15 Oct 2019 Results presented in a Mundipharma GmbH Media Release.
  • 15 Oct 2019 According to a Mundipharma GmbH media release, data will be presented at the European Society for Emergency Medicine (EUSEM) Congress 2019.
  • 18 Jan 2019 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top